This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
In: News
María José Alonso Receives the 2025 Hamilton Medal from Queen’s University Belfast
April 16, 2025The Hamilton Medal, established in memory of Aileen Hamilton, a distinguished member of the staff at Queen’s University’s School of Pharmacy, celebrates excellence in pharmaceutical research and innovation.
Read More
María José Alonso is inducted into the National Academy of Pharmacy and Biochemistry of Argentina
November 28, 2024Her inaugural speech as Corresponding Academic focused on ‘Pharmaceutical Nanotechnology as a Key Player in the Paradigm of Advanced Therapies’
Read More
Check out our new article: ‘Bioinspired orthogonal-shaped protein–biometal nanocrystals enable oral protein absorption’ – FULL-TEXT ACCESS
November 22, 2024Publication: Matilde Durán-Lobato, Sulay Tovar, Juan Cuñarro, Rocío Ramos-Membrive, Iván Peñuelas, Ilaria Marigo, Federico Benetti, Miguel Chenlo, Clara V. Álvarez, Vashegyi Ildikó, Rudolf Urbanics, János Szebeni, María José Alonso, Bioinspired orthogonal-shaped protein–biometal nanocrystals enable oral protein absorption, Journal of Controlled Release, Volume 377, 2025, Pages 17-36, ISSN 0168-3659, https://doi.org/10.1016/j.jconrel.2024.11.016
Read More
María José Alonso’s group collaborates in a project promoted by La Caixa Foundation and led by the CNIO that draw up a therapeutic strategy to combat heart diseases
November 13, 2024La Caixa Foundation has selected 29 new biomedical research projects of excellence with great social impact within the CaixaResearch call for Health Research 2024
Read More
Check out our new article: ‘Formulation of protein-loaded nanoparticles via freeze-drying’ – FULL-TEXT ACCESS
September 30, 2024Publication: Durán-Lobato, M., Tovar, S., de Oliveira Diz, T. et al. Formulation of protein-loaded nanoparticles via freeze-drying. Drug Deliv. and Transl. Res. (2024). https://doi.org/10.1007/s13346-024-01712-9
Read More
Don’t miss this outstanding review article published by Nature Nanotechnology: ‘A translational framework to DELIVER nanomedicines to the clinic’
September 23, 2024Publication: Joyce, P., Allen, C.J., Alonso, M.J. et al. A translational framework to DELIVER nanomedicines to the clinic. Nat. Nanotechnol. (2024). https://doi.org/10.1038/s41565-024-01754-7
Read More
Check out our new article: ‘Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity’ – OPEN ACCESS
August 19, 2024Publication: Mireya L. Borrajo, Aloia Quijano, Philipp Lapuhs, Ana I. Rodriguez-Perez, Shubaash Anthiya, José L. Labandeira-Garcia, Rita Valenzuela, María José Alonso, Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity, Journal of Controlled Release, Volume 372, 2024, Pages 295-303, ISSN 0168-3659, https://doi.org/10.1016/j.jconrel.2024.06.051
Read More
Check out our new article: ‘Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors’ – OPEN ACCESS
July 19, 2024Ana M. López-Estévez, Lucía Sanjurjo, Ángela Turrero, Iker Arriaga, Nicola G.A. Abrescia, Ana Poveda, Jesús Jiménez-Barbero, Anxo Vidal, Dolores Torres, María José Alonso, Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors, Journal of Controlled Release, Volume 373, 2024, Pages 277-292, ISSN 0168-3659,
https://doi.org/10.1016/j.jconrel.2024.07.032
Check out our new article: ‘Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights’ – OPEN ACCESS
July 12, 2024López-Estévez, A.M., Zhang, Y., Medel, M. et al. Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights. Nano Res. (2024). https://doi.org/10.1007/s12274-024-6826-8
Read More
For those of you interested in doing a PhD in Nanomedicine: second call open for the IMDEA Nanociencia Doctoral Training Programme
July 11, 2024IDEAL PhD is the IMDEA Nanociencia PhD Programme co-funded by the Horizon Europe Marie Skłodowska-Curie Actions COFUND programme.
IDEAL PhD second call will attract 6 pre-doctoral researchers to carry out their thesis projects in one of the research areas developed at the Institute.
The second call for IDEAL PhD closes on 23rd August, 2024.